host defence in the lung 3 Flashcards

1
Q

innate vs adaptive immunity

A
  • Two systems intimately closely interrelated
  • Initial responses to pathogens often innate
  • Adaptive responses are later, pathogen and antigen-specific and generate ‘memory’ with a learned response that is more rapid and effective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antigen

A

Molecule capable of inducing a specific immune response on the part of the host organism. Can be proteins, polysaccharide, lipids, DNA etc; soluble or part of a cell or pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cells of adaptive immune system

A

antigen presenting cells (innate/adaptive interface) - taste the environment, phagocytose foreign material, process and present antigen in lymphoid tissue
Lymphocytes (adaptive effector cells) - T cells , B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T cells

A
  • Cytotoxic T cells (Tc) express the surface molecule CD8. When activated they kill tumour and virus-infected cells that express the activating antigen
  • T helper (Th) cells express CD4.When activated they orchestrate the immune response by cytokine production. Different subsets of Th cells have different helper functions eg activating innate immune cells, assisting B cells to make antibodies.
  • T regulatory (Treg) cells suppress autoreactive lymphocytes to prevent them from attacking our own antigens.
  • Memory T cells enable enhanced future responses to the same antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where are T and B cells generated ?

A

primary lymphoid tissue - bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where are T and B cells activated?

A

secondary lymphoid tissue e.g. tonsils, thymus, spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

B cells

A
  • The unique B cell receptor is an immobilised antibody
  • When activated by specific antigen a B cell becomes a plasma cell which exists (for days) to make antibodies that bind the antigen
  • Each antibody recognises a specific epitope (part of an antigen)
  • Antibodies have a number of actions eg helping innate cells to ‘eat’ bacteria
  • Memory B cells allow rapid and augmented response to subsequent infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

properties of the adaptive immune system

A

Ability to mount specific responses to a huge range of pathogen-derived antigens (diversity)
• Avoids reacting to “self” antigens (self-tolerance)
• Development of immunological memory, with each pathogen ‘remembered’ by long-lived memory B and T cells. Enables a more rapid and effective second response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do lymphocytes recognize specific antigens?

A
  • T cells and B cells express different unique antigen receptors (the B cell receptor and the T cell receptor)
  • The variable region determines the receptor specificity, binding to antigen like a lock and key
  • Estimated to be approx. 1018 different antigen receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diversity and specificity in adaptive immunity

A
  • Generation of pathogen-specific variable regions in lymphocyte receptors is the basis of diversity and specificity
  • Much diversity is generated early in development via DNA rearrangements (VDJ recombination)
  • Exposure to relevant antigen triggers replication with errors in variable region DNA replication generating further diversity (somatic hyper-mutation)
  • Selection for higher affinity clones (affinity maturation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do we get millions of unique T and B cells?

A

Random recombination events occur between about 50 Variable (V) 27 Diversity (D) and 6 Joining (J) segments in both heavy and light chains
Recombination is not precise (nucleotides inserted or deleted) greatly increasing diversity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

B cell and T cell receptors are slightly different

A
  • B-cell receptors recognize antigen in native form (as they exist in nature) as well as presented antigen.
  • B cells may receive help from T cells. This enables them to respond to certain antigens more effectively
  • T-cell receptors can only recognise antigens that have been broken down and presented by an MHC (major histocompatibility complex) protein by an antigen presenting cell (APC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MHC molecule

A
  • MHC stands for Major Histocompatibility Complex, a series of cell surface proteins found on immune and non-immune cells that are essential for T cells to recognise antigens
  • MHC (HLA) molecules vary between individuals and in the setting of organ transplants they are highly immunogenic (HLA mis-matching leads to transplant rejection)
  • MHC class 1 molecules are expressed on all nucleated cells and enable cytotoxic T cells to recognise and kill viral-infected cells
  • MHC class 2 molecules are expressed by antigen presenting cells and are co-expressed with antigen to enable the activation of helper T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immune tolerance

A
  • A state of unresponsiveness of the immune system to antigens that normally have the capacity to elicit an adaptive immune response
  • Tolerance can be to self, but also to the fetus in pregnancy, or it can develop to pathogens (chronic infections) or cancers
  • Failure to establish self-tolerance leads to autoimmune disease, where our immune system attacks our own antigens. Examples include rheumatoid arthritis and , systemic lupus erythematosus
  • Self-tolerance arises both centrally and peripherally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Central tolerance

A

In the thymus or bone marrow, lymphocytes that react with self-antigens are deleted or develop into suppressor ‘Tregs’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Peripheral tolerance

A

In lymph nodes, autoreactive clones escaping central tolerance are deleted or suppressed by Tregs

17
Q

Immunological memory

A
  • Allows rapid immunological response on subsequent exposure
  • Following activation a small proportion of high affinity B and T cells differentiate into long-lived memory cells, residing in lymph nodes or tissues
  • Memory cells are distinguished from naïve cells by high affinity receptors, increased lifespan, and faster and stronger response to stimulation
18
Q

recognition and killing of pathogens

A
  • Activated cytotoxic T cells (CD8 +ve) kill virus-infected or tumour cells
  • Activated helper T cells (CD4 +ve) produce cytokines to orchestrate immune response and ‘help’ other cells. Many subsets with different helper functions
  • Activated B cells become plasma cells and produce specific antibodies to kill or limit pathogens and help innate immune cells eat them
19
Q

vaccination

A
  • Vaccination harnesses immunological memory to enhance adaptive immunologic responses to pathogens
  • Vaccines are derived from pathogens (eg dead or attenuated bacteria, capsular polysaccharide, viral proteins)
  • Vaccines can prevent infection or reduce morbidity in individuals, and also generate ‘herd immunity’
  • Booster doses better harness immunological memory and generate high affinity antibodies
20
Q

when it goes wrong

A
  • Failure of antibody production leads to recurrent or severe bacterial infections
  • Failure of T cell function leads to ‘opportunistic’ infections such as fungi and viruses, and tumours
  • Failure of tolerance leads to autoimmune disease
  • Failure to eliminate pathogens (and autoimmune disease) leads to chronic inflammation
21
Q

failure of T cell immunity

A
  • Primary (rare immunodeficiencies) or secondary (immunosuppressive drugs, HIV infection)
  • Typical and ‘opportunisitic’ infections (which do not cause disease in healthy individuals)
  • Fungi (pneumocystis, aspergillus, cryptococcus)
  • Viruses – disseminated CMV or EBV
  • Bacteria eg pneumonia and TB
  • Parasites eg toxoplasma, cryptosporidia
  • Increase in some malignancies
22
Q

HIV and T-helper cells

A
  • Acquired immune deficiency syndrome (AIDS) is caused by HIV, a retrovirus spread by bodily fluids
  • HIV infects CD4+ (T helper) cells
  • Untreated CD4+ levels progressively decline leading to AIDS, a failure of cell-mediated immunity
  • Highly active anti-retroviral therapy (HAART) reduces viral burden and maintains the immune system for years but globally HIV-related lung disease remains a major cause of death
23
Q

Failed tolerance (autoimmune disease)

A
  • Failure of immunological tolerance to “self”
  • Most autoimmunity occurs later in life due to failure of peripheral tolerance; initiating events are often unclear
  • Genetic associations (with MHC), commoner in women
  • Clonal proliferation of autoreactive lymphocytes with target-specific tissue destruction (or activation)
  • Examples include rheumatoid arthritis (anti-citrullinated proteins), Graves disease (anti-TRH receptor), vasculitis (anti-neutrophil)
24
Q

What causes inflammation to be chronic?

A
  1. Initiating cause persists
    Persistent infection – eg mycobacteria, abscess
    Persisting irritant eg smoking, gallstones
    Foreign bodies eg inhalation of food
  2. cellular response is inappropriate
    autoimmunity eg rheumatoid arthritis
    granulomatous disease eg sarcoidosis
  3. structural abnormalities
    bronchiectasis – local defences malfunction
    diverticular disease
25
Q

Patterns of chronic inflammation

A
  • Chronic suppurative inflammation – mostly innate cells (neutrophils) often surrounded by a capsule of chronic inflammatory cells or fibrous tissue
  • Chronic autoimmune inflammation (mostly cells of adaptive immune system). May lead to fibrosis
  • Chronic granulomatous inflammation (mostly cells of adaptive immune system). May lead to fibrosis.
26
Q

Consequences of chronic inflammation

A
  • Systemic – malaise, weight loss, fever, sweats, anaemia
  • Tissue Destruction – eg cavity formation
  • Fibrosis – eg strictures, organ dysfunction
  • Growth disorders – metaplasia, neoplasia e.g. carcinoma of bronchus in pulmonary fibrosis
27
Q

Treatment of chronic inflammation

A

Cause-specific treatments first, if available (e.g. treatment of chronic infection, surgical procedures to removal of foreign material)
Anti-inflammatory treatment NSAIDs, steroids
Immunsuppression – can target specific cell types (eg T cells or B cells) or specific cytokines. Consequences include increased infection